Indian Exchange: Awfis Space Solutions And 2 Stocks That May Be Trading Below Estimated Value

Simply Wall St · 10/17 01:06

The Indian market has shown strong performance with a 1.0% increase over the last week and a remarkable 39% rise over the past year, while earnings are projected to grow by 17% annually. In such a robust environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to capitalize on undervalued assets.

Top 10 Undervalued Stocks Based On Cash Flows In India

Name Current Price Fair Value (Est) Discount (Est)
Apollo Pipes (BSE:531761) ₹553.65 ₹1106.50 50%
Titagarh Rail Systems (NSEI:TITAGARH) ₹1133.00 ₹2144.97 47.2%
RITES (NSEI:RITES) ₹304.50 ₹516.92 41.1%
IOL Chemicals and Pharmaceuticals (BSE:524164) ₹433.00 ₹762.32 43.2%
Vedanta (NSEI:VEDL) ₹486.70 ₹905.55 46.3%
Patel Engineering (BSE:531120) ₹54.41 ₹91.98 40.8%
Orchid Pharma (NSEI:ORCHPHARMA) ₹1368.45 ₹2142.32 36.1%
Tarsons Products (NSEI:TARSONS) ₹417.25 ₹707.09 41%
Manorama Industries (BSE:541974) ₹923.80 ₹1665.51 44.5%
Strides Pharma Science (NSEI:STAR) ₹1630.95 ₹2704.30 39.7%

Click here to see the full list of 26 stocks from our Undervalued Indian Stocks Based On Cash Flows screener.

Underneath we present a selection of stocks filtered out by our screen.

Awfis Space Solutions (NSEI:AWFIS)

Overview: Awfis Space Solutions Limited offers flexible workspace solutions in India with a market cap of ₹53.02 billion.

Operations: The company's revenue is primarily derived from Co-Working Space on Rent and Allied Services at ₹6.65 billion, followed by Construction and Fit-Out Projects contributing ₹2.29 billion.

Estimated Discount To Fair Value: 14.5%

Awfis Space Solutions, trading at ₹755.2, is undervalued relative to its estimated fair value of ₹883.32. Despite a volatile share price recently, the company shows promising revenue growth forecasts of 28.8% annually, surpassing market expectations. Earnings are projected to grow significantly by 89.27% per year and become profitable within three years, indicating robust cash flow potential. Recent business expansions in GIFT City and Pune enhance its strategic positioning in India's flexible workspace market.

NSEI:AWFIS Discounted Cash Flow as at Oct 2024
NSEI:AWFIS Discounted Cash Flow as at Oct 2024

Strides Pharma Science (NSEI:STAR)

Overview: Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products across various regions including Africa, Australia, North America, Europe, Asia, India, and internationally with a market cap of ₹144 billion.

Operations: The company's revenue is primarily generated from its Pharmaceutical Business (excluding Bio-Pharmaceutical Business), amounting to ₹42.09 billion.

Estimated Discount To Fair Value: 39.7%

Strides Pharma Science, priced at ₹1630.95, is trading 39.7% below its estimated fair value of ₹2704.3, reflecting potential undervaluation based on cash flows. The company is forecasted to achieve profitability in the next three years with earnings growth projected at 99.48% annually, outpacing market averages. Recent debt redemption actions have reduced outstanding non-convertible debentures significantly to ₹242 million, potentially improving financial flexibility and supporting future growth prospects.

NSEI:STAR Discounted Cash Flow as at Oct 2024
NSEI:STAR Discounted Cash Flow as at Oct 2024

Titagarh Rail Systems (NSEI:TITAGARH)

Overview: Titagarh Rail Systems Limited manufactures and sells freight and passenger rail systems in India and internationally, with a market cap of ₹152.59 billion.

Operations: The company's revenue is derived from two main segments: Passenger Rail Systems, contributing ₹3.32 billion, and Freight Rail Systems (including shipbuilding, bridges, and defense), generating ₹35.14 billion.

Estimated Discount To Fair Value: 47.2%

Titagarh Rail Systems, trading at ₹1133, is significantly undervalued with a fair value estimate of ₹2144.97. Despite recent shareholder dilution, the company shows promising growth potential with forecasted revenue and earnings growth rates of 25.7% and 30.1% per year respectively, outpacing the Indian market averages. Recent strategic adjustments in wagon orders with Indian Railways have optimized capacity utilization while avoiding penalties, enhancing operational efficiency and cash flow management.

NSEI:TITAGARH Discounted Cash Flow as at Oct 2024
NSEI:TITAGARH Discounted Cash Flow as at Oct 2024

Turning Ideas Into Actions

Interested In Other Possibilities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.